9 Followers HKEX:1061 - Essex Bio-Technology Ltd

Essex Bio-Technology Ltd
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend ¹
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2009 Q2	2010 Q2	2011 Q2	2011 Q4	2012 Q2	2012 Q4	2013 Q2	2013 Q4	2014 Q2	2014 Q4	2015 Q2	2015 Q4	2016 Q2	2016 Q4	2017 Q2	2017 Q4	2018 Q2	2018 Q4	2019 Q2	2019 Q4	2020 Q2	2020 Q4	2021 Q2	2021 Q4	2022 Q2	2022 Q4	2023 Q2	2023 Q4	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	737.37M 12.7%	900.29M 22.1%	655.83M -27.2%	661.89M 0.9%	899.36M 35.9%	807.2M -10.2%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	114.68M -0.4%	127.21M 10.9%	69.18M -45.6%	59.2M -14.4%	88.9M 50.2%	78.37M -11.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	622.69M 15.5%	773.07M 24.1%	586.64M -24.1%	602.69M 2.7%	810.46M 34.5%	728.83M -10.1%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	556.26M 15.3%	668.52M 20.2%	507.09M -24.1%	529.16M 4.4%	709.62M 34.1%	685.26M -3.4%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	441.58M 20.2%	541.31M 22.6%	437.91M -19.1%	469.96M 7.3%	620.72M 32.1%	606.89M -2.2%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	181.12M 5.4%	231.77M 28.0%	148.73M -35.8%	132.72M -10.8%	189.74M 43.0%	121.94M -35.7%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	183.07M -5.2%	211.38M 15.5%	162.7M -23.0%	97.64M -40.0%	204.85M 109.8%	141.16M -31.1%
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	162.19M -4.4%	183.78M 13.3%	139.23M -24.2%	86.18M -38.1%	169.81M 97.0%	105.45M -37.9%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.281 -4.3%	0.319 13.4%	0.242 -24.1%	0.151 -37.8%	0.297 97.3%	0.185 -37.6%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.274 -4.8%	0.307 12.3%	0.235 -23.5%	0.148 -37.2%	0.288 95.1%	0.181 -37.2%